Table 5.

NLR and PLR of Hsp90-beta level in BALF and serum

NLR and PLR of Hsp90-beta BALF concentration in lung cancer patients and benign lung diseases patients
Interval	Positive	Negative	Likelihood ratio	95% CI
0.0-0.2	1	19	0.0251	0.00348 to 0.181
0.2-0.4	2	12	0.0795	0.0186 to 0.339
0.4-0.6	6	5	0.572	0.185 to 1.766
0.6-0.8	6	4	0.715	0.213 to 2.396
0.8-1.0	16	1	7.628	1.047 to 55.567
1.0-1.2	46	0	∞	2.771 to ∞
1.2-1.4	9	0	∞	0.510 to ∞
Total	86	41
NLR and PLR of Hsp90-beta serum concentration in lung cancer patients and benign lung diseases patients
Interval	Positive	Negative	Likelihood ratio	95% CI
0.0-0.5	0	27	0.000	0.000 to 0.141
0.5-1.0	3	11	0.130	0.0383 to 0.441
1.0-1.5	19	1	9.058	1.255 to 65.358
1.5-2.0	57	0	∞	3.443 to ∞
2.0-2.5	4	2	0.953	0.182 to 4.995
2.5-3.0	3	0	∞	0.147 to ∞
Total	86	41

NLR, negative likelihood ratio; PLR, positive likelihood ratio; 95% CI, 95% confidence interval; BALF, bronchoalveolar lavage fluid.